News from the FDA/CDC
News
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for Crohn’s disease
Risankizumab is already approved in the United States for the treatment of adults with active psoriatic arthritis and moderate to severe plaque...
News from the FDA/CDC
FDA warning released for Volara respiratory system
News from the FDA/CDC
FDA adds RA indication for Riabni rituximab biosimilar
Riabni is the second rituximab biosimilar to be approved for rheumatoid arthritis in the United States.
News
FDA denies petition to disqualify researchers over controversial ketamine studies
“The FDA denied our petition, and we think that sends the wrong signal to the research community.”
News
FDA approves first drug for eosinophilic esophagitis
Dupilumab (Dupixent) is approved to treat eosinophilic esophagitis in adults and children aged 12 years and older weighing at least 40 kg.
News from the FDA/CDC
FDA-cleared panties could reduce STI risk during oral sex
“I wanted to feel sexy and confident and use something that was made with my body and actual sex in mind.”
News
FDA approves two vonoprazan therapies for H. pylori eradication
“H. pylori eradication rates continue to decline in part due to antibiotic resistance, inadequate acid suppression, and complex treatment...
News from the FDA/CDC
CDC reports first human case of H5 bird flu in the U.S.
News from the FDA/CDC
Upadacitinib earns FDA approval for ankylosing spondylitis
Janus kinase inhibitor offers oral option for patients who have who have had an insufficient response or intolerance with one or more tumor...
News from the FDA/CDC
CDC panel lists reasons to get second COVID booster
One panelist said she was concerned about the potential for “booster fatigue.”